-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Bicycle Therapeutics, Maintains $29 Price Target

Benzinga·05/02/2025 12:22:28
Listen to the news
Needham analyst Ami Fadia reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintains $29 price target.